Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...

全面介紹

Saved in:
書目詳細資料
Main Authors: Qi-An Chen (Author), Wei-Hao Lin (Author), Xiao-Xiang Zhou (Author), Zheng Cao (Author), Xiao-Li Feng (Author), Yi-Bo Gao (Author), Jie He (Author)
格式: 圖書
出版: Elsevier, 2024-02-01T00:00:00Z.
主題:
在線閱讀:Connect to this object online.
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

Connect to this object online.

3rd Floor Main Library

持有資料詳情 3rd Floor Main Library
索引號: A1234.567
復印件 1 可用